Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

12.13
BATS BZX Real-Time Price
As of 1:09pm ET
 +0.23 / +1.93%
Today’s Change
5.53
Today|||52-Week Range
13.84
+7.35%
Year-to-Date

Today’s Trading

Previous close11.90
Today’s open12.06
Day’s range12.01 - 12.24
Volume483,741
Average volume (3 months)1,277,922
Market cap$1.3B
Dividend yield--
Data as of 12:55pm ET, 06/30/2015

Growth & Valuation

Earnings growth (last year)+39.39%
Earnings growth (this year)-43.96%
Earnings growth (next 5 years)+5.61%
Revenue growth (last year)+115.03%
P/E ratioNM
Price/Sales11.48
Price/Book--

Competitors

 Today’s
change
Today’s
% change
TXMDTherapeuticsMD Inc+0.29+3.89%
ZSPHZS Pharma Inc+0.25+0.49%
RGENRepligen Corp-0.34-0.82%
RPTPRaptor Pharmaceutica...+0.36+2.33%
Data as of 1:07pm ET, 06/30/2015

Financials

Next reporting dateAugust 6, 2015
EPS forecast (this quarter)-$0.30
Annual revenue (last year)$102.8M
Annual profit (last year)-$83.3M
Net profit margin-81.06%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert J. Mulroy
Head-
Corporate Operations
William M. McClements
Corporate headquarters
Cambridge, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers